XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Sep 17, 2025, 4:00 PM EDT - Market closed
XWELL Market Cap
XWELL has a market cap or net worth of $6.10 million as of September 18, 2025. Its market cap has decreased by -38.90% in one year.
Market Cap
6.10M
Enterprise Value
7.88M
1-Year Change
-38.90%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since July 20, 2012, XWELL's market cap has decreased from $50.81M to $6.10M, a decrease of -87.99%. That is a compound annual growth rate of -14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 6.04M | -23.84% |
| Dec 31, 2024 | 7.94M | 9.13% |
| Dec 29, 2023 | 7.27M | -75.92% |
| Dec 30, 2022 | 30.20M | -85.80% |
| Dec 31, 2021 | 212.76M | 90.15% |
| Dec 31, 2020 | 111.89M | 994.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |